United States Advanced Drug Delivery CDMO Market Insight

• The United States pharmaceutical CDMO market was valued at nearly USD 43.7 billion in 2025 and is projected to grow steadily owing to increasing outsourcing of advanced therapies, biologics manufacturing, and complex drug delivery systems.
• Increasing investments in AI-driven formulation technologies, personalized medicine platforms, and advanced injectable drug delivery systems are expected to fuel market growth in the coming years, as modern delivery platforms improve therapeutic efficiency by nearly 40% while reducing dosage variability and improving patient compliance

What Makes Decisions Advisors Research Unique?

• Intelligent Market Research Based on AI for Pharmaceutical CDMO & Drug Delivery Technologies

Decisions Advisors offers intelligent market research that includes advanced analysis of drug delivery technologies, pharmaceutical outsourcing trends, biologics manufacturing solutions, and AI-enabled formulation systems. Our research identifies growth opportunities, technology adoption trends, competitive positioning, and strategic developments in the United States Advanced Drug Delivery CDMO Market.

• Highly Effective Research Approaches with Accurate Forecast Analysis

The research process utilizes advanced methodologies including primary interviews, pharmaceutical value chain tracking, clinical manufacturing analysis, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology outlooks. The study evaluates demand across oncology therapeutics, biologics manufacturing, injectable formulations, gene therapies, and personalized medicine applications in the United States.

• Highly Competitive Environment Analysis

The report provides in-depth analysis of major CDMO players, advanced drug delivery innovations, formulation technology advancements, product launch activities, and strategic collaborations. The report also evaluates pharmaceutical regulations, research and development activities, manufacturing capacity expansion, and emerging opportunities available in the United States Advanced Drug Delivery CDMO Market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States Advanced Drug Delivery CDMO Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Companies in United States Advanced Drug Delivery CDMO Market

• Lonza Group AG
• Catalent, Inc.
• Thermo Fisher Scientific Inc.
• Recipharm AB
• Samsung Biologics Co., Ltd.
• Evonik Industries AG
• WuXiAppTec Co., Ltd.
• Baxter BioPharma Solutions
• PCI Pharma Services
• Charles River Laboratories International, Inc.

Recent Developments:

• In September 2025, Catalent, Inc. expanded its advanced biologics and lipid nanoparticle formulation capabilities to support next-generation mRNA and gene therapy drug delivery applications.
• In May 2025, Thermo Fisher Scientific Inc. introduced integrated CDMO solutions for complex injectable therapies and personalized drug delivery systems aimed at improving clinical manufacturing efficiency.

Market Segmentation:

United States Advanced Drug Delivery CDMO Market, By Drug Delivery Technology

• Nanoparticle-Based Drug Delivery Systems
• Liposomal & Lipid-Based Delivery Platforms
• Injectable Controlled Release Systems
• Transdermal Drug Delivery Technologies
• Targeted Biologic Delivery Systems

United States Advanced Drug Delivery CDMO Market, By Service Type

• Preformulation& Formulation Development
• Analytical & Characterization Services
• Clinical Manufacturing Services
• Commercial Manufacturing Services
• Packaging & Stability Testing Services

United States Advanced Drug Delivery CDMO Market, By Application

• Oncology Therapeutics
• Gene & Cell Therapy
• Infectious Disease Treatment
• Cardiovascular & Metabolic Disorders
• Neurological & Rare Disease Therapies

Expert Views:

The United States advanced drug delivery CDMO market will grow a lot. This is because more pharmaceutical companies are outsourcing their manufacturing.There is also a rising demand for biologics and personalized medicine.New technologies in targeted drug delivery are emerging rapidly.The use of AI-based formulation systems will improve manufacturing efficiency.Lipid nanoparticle technologies will also play a role in this growth.Precision therapeutic platforms will accelerate demand.This demand will be seen across areas such as oncology.Gene therapy, biologics and advanced injectable therapeutic applications will also see an increase, in demand.The United States advanced drug delivery CDMO market is expected to benefit from these advancements.

Author: Govind and Krishna By Spherical Insights and Consulting